Literature DB >> 6470731

Pattern electroretinogram in multiple sclerosis.

G Serra, M Carreras, V Tugnoli, M Manca, M C Cristofori.   

Abstract

The pattern electroretinogram obtained in patients affected by multiple sclerosis were compared with those in a normal population. The pattern electroretinogram amplitude in multiple sclerosis optic neuritis frequently appeared normal, but pattern electroretinogram amplitude abnormalities were found in patients suffering from recurrent multiple sclerosis optic neuritis. Pattern electroretinogram examination appears a useful method in the differential diagnosis between axonal and demyelinating optic nerve impairment.

Entities:  

Mesh:

Year:  1984        PMID: 6470731      PMCID: PMC1027957          DOI: 10.1136/jnnp.47.8.879

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  A gold foil electrode: extending the horizons for clinical electroretinography.

Authors:  G B Arden; R M Carter; C Hogg; I M Siegel; S Margolis
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-04       Impact factor: 4.799

2.  Simultaneous electroretinograms and visually evoked potentials from adult amblyopes in response to a pattern stimulus.

Authors:  S Sokol; D Nadler
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-08       Impact factor: 4.799

3.  Changes in the electroretinogram in patients with optic nerve lesions.

Authors:  M Feinsod; H Rowe; E Auerbach
Journal:  Doc Ophthalmol       Date:  1971-05-14       Impact factor: 2.379

4.  Simultaneous electroretinograms and evoked potentials.

Authors:  J C Armington
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  The pathophysiology of amblyopia: electrophysiological studies.

Authors:  D M Levi; R E Manny
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Clinical and experimental evidence that the pattern electroretinogram (PERG) is generated in more proximal retinal layers than the focal electroretinogram (FERG).

Authors:  G B Arden; C R Hogg
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

8.  Neurophysiological investigation in optic nerve disease: combined assessment of the visual evoked response and electroretinogram.

Authors:  H Ikeda; K E Tremain; M D Sanders
Journal:  Br J Ophthalmol       Date:  1978-04       Impact factor: 4.638

9.  The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway.

Authors:  A Fiorentini; L Maffei; M Pirchio; D Spinelli; V Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-09       Impact factor: 4.799

10.  Improved electrode for electroretinography.

Authors:  W W Dawson; G L Trick; C A Litzkow
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

View more
  4 in total

1.  Pattern electroretinogram as a function of spatial frequency after retrobulbar optic neuritis.

Authors:  B Falsini; A Bardocci; S Cermola; V Porciatti; G Porrello
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction.

Authors:  G E Holder
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

3.  Pattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunction.

Authors:  G E Holder
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

4.  A three-year longitudinal study of retinal function and structure in patients with multiple sclerosis.

Authors:  James V M Hanson; Mei-Yee Ng; Helen K Hayward-Koennecke; Sven Schippling; Kelly A Reeve; Christina Gerth-Kahlert
Journal:  Doc Ophthalmol       Date:  2021-10-27       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.